- Home
- IDAI vs SILO Comparison
IDAI vs SILO Comparison
Compare IDAI & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- SILO
- Stock Information
- Founded
- IDAI 2016
- SILO 2010
- Country
- IDAI United States
- SILO United States
- Employees
- IDAI N/A
- SILO N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- SILO Apparel
- Sector
- IDAI Technology
- SILO Consumer Discretionary
- Exchange
- IDAI Nasdaq
- SILO Nasdaq
- Market Cap
- IDAI 4.9M
- SILO 4.5M
- IPO Year
- IDAI N/A
- SILO N/A
- Fundamental
- Price
- IDAI $3.16
- SILO $0.57
- Analyst Decision
- IDAI
- SILO
- Analyst Count
- IDAI 0
- SILO 0
- Target Price
- IDAI N/A
- SILO N/A
- AVG Volume (30 Days)
- IDAI 67.5K
- SILO 312.4K
- Earning Date
- IDAI 08-12-2025
- SILO 08-12-2025
- Dividend Yield
- IDAI N/A
- SILO N/A
- EPS Growth
- IDAI N/A
- SILO N/A
- EPS
- IDAI N/A
- SILO N/A
- Revenue
- IDAI $3,054,143.00
- SILO $72,102.00
- Revenue This Year
- IDAI $65.46
- SILO $1.86
- Revenue Next Year
- IDAI $12.00
- SILO N/A
- P/E Ratio
- IDAI N/A
- SILO N/A
- Revenue Growth
- IDAI N/A
- SILO N/A
- 52 Week Low
- IDAI $1.43
- SILO $0.41
- 52 Week High
- IDAI $18.75
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- IDAI 58.37
- SILO 45.29
- Support Level
- IDAI $2.80
- SILO $0.55
- Resistance Level
- IDAI $3.53
- SILO $0.69
- Average True Range (ATR)
- IDAI 0.36
- SILO 0.04
- MACD
- IDAI 0.04
- SILO 0.00
- Stochastic Oscillator
- IDAI 58.33
- SILO 28.57
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.